Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metasta...

Martin M., Zielinski C., Ruiz-Borrego M., Carrasco E., Turner N., Ciruelos E. M., Muñoz M., Bermejo B., Margeli M., Anton A., Kahán Zsuzsanna, Csöszi Tibor, Casas M. I., Murillo L., Morales S.
2021